Skip to main content
Premium Trial:

Request an Annual Quote

staff reporter

Articles Authored by staff reporter

Mar 31, 2023

Apollomics Completes SPAC Merger, Begins Public Trading on Nasdaq

Mar 31, 2023

Ablaze Pharmaceuticals to Develop RayzeBio's GPC3-Targeted Radiotherapy

Mar 31, 2023

In Brief This Week: Allarity Therapeutics, Immutep, Thermo Fisher Scientific

Mar 31, 2023

EMA's CHMP Recommends BMS's Breyanzi as Second-Line Lymphoma Treatment

Mar 30, 2023

Exai Bio, Quantum Leap Healthcare Collaborative Expand Participation in RNA Liquid Biopsy Trial

Mar 30, 2023

Omega Therapeutics, Roche Partner for Phase I/II Trial in MYC-Driven Hepatocellular Carcinoma

Mar 30, 2023

Merck Nabs Full FDA Approval for Keytruda in MSI-High, dMMR Solid Tumors

Mar 30, 2023

PDS Biotech to Begin Phase III Trial of Immunotherapy in HPV 16-Positive Head and Neck Cancer

Mar 29, 2023

NCCN Adds Mirati Therapeutics' Krazati to Guidelines for KRAS-Mutant NSCLC With Brain Metastases

Mar 29, 2023

European Commission Approves Libtayo in PD-L1-Positive Non-Small Cell Lung Cancer